Table 4 Multivariable regression analyses on predictors of CINV in the very late period (days 6 to 21) in patients with a CR during the overall observation period
Odds Ratioa | 95% CI | P-value | |
|---|---|---|---|
Cycle 1 (n = 98) | |||
Motion sickness | 1.50 | 0.21; 10.9 | 0.687 |
Pregnancy-related morning sickness | 0.40 | 0.05; 3.00 | 0.376 |
Alcohol intake (every day vs. none) | Not estimable | Not estimable | Not estimable |
Age (≥50 vs. < 50 years) | 0.69 | 0.10; 4.90 | 0.707 |
Nausea over last 24 h (0–10 NRS) | 0.74 | 0.53; 1.03 | 0.077 |
Anxiety over last 24 h (0–10 NRS) | 0.88 | 0.66; 1.17 | 0.390 |
Cycle 2 (n = 98) | |||
Motion sickness | 1.50 | 0.25; 9.07 | 0.660 |
Pregnancy-related morning sickness | 0.51 | 0.10; 2.70 | 0.429 |
Alcohol intake (every day vs. none) | 1.05 | 0.10; 11.6 | 0.968 |
Age (≥50 vs. < 50 years) | 0.30 | 0.05; 1.86 | 0.197 |
Pre-chemotherapy nausea (0–10 NRS) | 0.97 | 0.64; 1.47 | 0.870 |
Pre-chemotherapy anxiety (0–10 NRS) | 0.92 | 0.65; 1.29 | 0.608 |
Cycle 3 (n = 100) | |||
Motion sickness | 0.44 | 0.10; 1.97 | 0.281 |
Pregnancy-related morning sickness | 0.67 | 0.16; 2.87 | 0.589 |
Alcohol intake (every day vs. none) | Not estimable | Not estimable | Not estimable |
Age (≥50 vs. < 50 years) | 2.16 | 0.47; 9.94 | 0.323 |
Pre-chemotherapy nausea (0–10 NRS) | 0.65 | 0.50; 0.85 | 0.001 |
Pre-chemotherapy anxiety (0–10 NRS) | 0.88 | 0.68; 1.15 | 0.354 |
Cycle 4 (n = 96) | |||
Motion sickness | 0.11 | 0.01; 1.03 | 0.053 |
Pregnancy-related morning sickness | 1.21 | 0.14; 10.6 | 0.862 |
Alcohol intake (every day vs. none) | 0.77 | 0.04; 16.3 | 0.868 |
Age (≥50 vs. < 50 years) | 0.11 | 0.01; 1.10 | 0.061 |
Pre-chemotherapy nausea (0–10 NRS) | 0.50 | 0.34; 0.74 | 0.0006 |
Pre-chemotherapy anxiety (0–10 NRS) | 1.16 | 0.78; 1.73 | 0.470 |